Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 287031011000036116 | aluminium hydroxide 200 mg / 5 mL + magnesium hydroxide 200 mg / 5 mL + simethicone 20 mg / 5 mL oral liquid, 5 mL measure (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 562371000036114 | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | Is a | aluminium hydroxide + magnesium hydroxide + simethicone | true | Inferred relationship | Some | ||
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | has intended active ingredient | aluminium hydroxide | true | Inferred relationship | Some | 394653006 | |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | has Australian BoSS | aluminium hydroxide | true | Inferred relationship | Some | 394653006 | |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | has intended active ingredient | magnesium hydroxide | true | Inferred relationship | Some | 193912334 | |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | has Australian BoSS | magnesium hydroxide | true | Inferred relationship | Some | 193912334 | |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | has intended active ingredient | simethicone | true | Inferred relationship | Some | 562427570 | |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | has Australian BoSS | simethicone | true | Inferred relationship | Some | 562427570 | |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | has manufactured dose form | oral liquid | true | Inferred relationship | Some | ||
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | has unit of use | measure | true | Inferred relationship | Some | 562427571 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mylanta Original oral liquid, 5 mL | Is a | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | Inferred relationship | Some | |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 750 mL | has MPUU | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | Inferred relationship | Some | 1 |
| Mylanta P Antacid oral liquid, 5 mL | Is a | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | Inferred relationship | Some | |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 500 mL | has MPUU | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | Inferred relationship | Some | 1 |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 200 mL | has MPUU | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | Inferred relationship | Some | 1 |
| Gelusil oral liquid, 5 mL | Is a | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR